Epidemiology

doi: 10.25005/2074-0581-2022-24-4-523-531
CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFLUENZA IN CHILDREN RESIDING IN THE ASTRAKHAN REGION

N.S. Larina1, R.S. Arakelyan2, L.A. Sivtsova3, A.R. Kurbangalieva3

1Department of Children's Infections, Astrakhan State Medical University, Astrakhan, Russian Federation
2Department of Infectious Diseases and Epidemiology, Astrakhan State Medical University, Astrakhan, Russian Federation
3Center for Hygiene and Epidemiology in the Astrakhan region, Astrakhan, Russian Federation

Objective: To study the clinical and epidemiological features of influenza in children of the Astrakhan region in 2016-2020

Methods: During the analyzed period, 1,276,150 patients with infectious and non-infectious diseases were registered on the territory of the Astrakhan region, of which 1,202,553 cases (94.2%) were infectious and parasitic diseases. The share of children in the structure of the general infectious and parasitic morbidity of the population of the Astrakhan region for the period of 2016-2020 amounted to 897,094 cases (74.6%), of which 844,299 patients (94.1%) developed influenza and other acute respiratory viral infections (ARVI), including influenza – 3,663 cases (0.4%) and other acute respiratory viral infections – 840,636 cases (99.6%).

Results: Influenza cases were registered in children of different ages both in the urban and rural districts of the Astrakhan region (3,405 cases – 93%, and 258 cases – 7% respectively). Influenza in children living in the Astrakhan region were registered in nine districts: Volodarsky, Ikryaninsky, Kamyzyaksky, Krasnoyarsky, Limansky, Narimanovskaya, Volga, Kharabalinsky districts and the city of Znamensk. In all cases, the children complained of weakness and fatigue. Most of the children (n=3,387; 92.5%) complained of fever up to 38-39ºС, sore throat (n=3,198; 87.3%), runny nose and nasal congestion (n=3,254; 88.8 %), headache (n=3,127; 85.4%). Myalgia and arthralgia were observed in 2,551 (69.6%) children. In rare cases, there were complaints of vomiting and diarrhea – in 233 (6.4%) and 474 (12.9%) children, respectively. The smallest number of cases of influenza was registered in children aged 5 to 12 months – 261 cases (7.1%); among children aged 1-7 years there were 2,145 cases (58.6%), and from 7 to 17 years – 1,257 cases (34.3%). Sore throat in most children (n=3,198; 93.9%) persisted for 3 to 5 days. A complicated course of influenza was not observed.

Conclusion: Children of all age groups are susceptible to influenza, but most often children aged 1 to 7 years are affected. Influenza was recorded most often in children living in urban areas. Complaints of children with influenza corresponded to those described in the literature.

Keywords: Influenza, children, schoolchildren, preschoolers, myalgia, arthralgia, fever, nasal congestion.

Download file:


References
  1. Tkhakushinova NH, Bevzenko OV Kliniko-epidemiologicheskaya kharkteristika grippa u detey v Krasnodarskom krae v epidemicheskom sezone 2021-2022 gg. [Clinical and epidemiological characteristics of influenza in children in the Krasnodar Territory in the epidemic season 2021-2022]. Rossiyskiy pediatricheskiy zhurnal. 2022;3(1):310.
  2. Gazina EI, Dorganeva KV, Aralova EV Osobennosti klinicheskogo techeniya oslozhnyonnogo grippa u detey [Features of the clinical course of complicated influenza in children]. Molodyozhnyy innovatsionnyy vestnik. 2013;2(1):97.
  3. Nikolaeva SV, Usenko DV, Shabalina SV, Khlypovka YuN, Medkova AYu, Gorelov AV. Osobennosti klinik sochetannykh form grippa u detey [Features of the clinical course of combined forms of influenza in children]. RMZh. Meditsinskoe obozrenie. 2020;1(11):665-9.
  4. Amvrosieva TV, Mitkovskaya NP, Bogush ZF, Arinovich AS, Balysh EM. Vozbuditeli virusnykh miokarditov [The causative agents of viral myocarditis]. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski. 2020;4(1):817-23.
  5. Krasnov VV Gripp i ORVI: ispol'zovanie rekombinantnogo interferona dlya lecheniya i profilaktiki u detey [Influenza and SARS: The use of recombinant interferon for treatment and prevention in children]. Praktika pediatra. 2019;1:24-9.
  6. Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68(6):895-902. https://doi. org/10.1093/cid/ciy874
  7. Uyeki TM. Influenza. Ann Intern Med. 2021;174(11):ITC161-ITC176. https:// doi.org/10.7326/AITC202111160
  8. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data. Lancet Respir Med. 2014;2(5):395- 404. https://doi.org/10.1016/S2213-2600(14)70041-4
  9. Lytras T, Mouratidou E, Andreopoulou A, Bonovas S, Tsiodras S. Effect of early oseltamivir treatment on mortality in critically ill patients with different types of influenza: A multiseason cohort Study. Clin Infect Dis. 2019;69(11):1896- 902. https://doi.org/10.1093/cid/ciz101
  10. Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, et al. Antivirals for treatment of influenza: A systematic review and meta-analysis of observational studies. Ann Intern Med. 2012;156(7):512-24. https://doi.org/10.7326/0003- 4819-156-7-201204030-00411
  11. Besschyotnova OksV, Volkova OA, Aliev ShI, Besschyotnova OlV. Otnoshenie molodyozhi k vaktsinoprofilaktike grippa v usloviyakh razvitiya pandemii COVID-19 [The attitude of the youth to vaccine prevention of influenza in conditions of COVID-19 pandemic]. Problemy sotsialnoy gigieny, zdravookhraneniya i istorii meditsiny. 2021;29(2):213-19. https://doi.org/10.32687/0869- 866X-2021-29-2-213-219
  12. Katzen J, Kohn R, Houk JL, Ison MG. Early oseltamivir after hospital admission is associated with shortened hospitalization: A 5-year analysis of oseltamivir timing and clinical outcomes. Clin Infect Dis. 2019;69(1):52-8. https://doi. org/10.1093/cid/ciy860
  13. Venkatesan S, Myles PR, Bolton KJ, Muthuri SG, Al Khuwaitir T, Anovadiya AP, et al. Neuraminidase inhibitors and hospital length of stay: A meta-analysis of individual participant data to determine treatment effectiveness among patients hospitalized with nonfatal 2009 pandemic influenza A (H1N1) virus infection. J Infect Dis. 2020;221(3):356-66. https://doi.org/10.1093/infdis/jiz152
  14. Welch SC, Lam SW, Neuner EA, Bauer SR, Bass SN. High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients. Intensive Care Med. 2015;41(7):1365-6. https://doi.org/10.1007/ s00134-015-3816-z
  15. Kumar D, Ison MG, Mira JP, Welte T, Hwan Ha J, Hui DS, et al. Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): A randomised, parallel-group, double-blind, placebo-controlled, superiority trial. Lancet Infect Dis. 2022;22(5):718-30. https://doi.org/10.1016/S1473-3099(21)00469-2
  16. de Jong MD, Ison MG, Monto AS, Metev H, Clark C, O'Neil B, et al. Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients. Clin Infect Dis. 2014;59(12):e172-85. https://doi.org/10.1093/cid/ciu632
  17. Stolyarov KA, Sominina AA, Smorodintseva EA, Shtaadegaard L, Peydzhet Dzh, Danilenko DM. Sravnitel'nyy analiz epidemiologii grippa i respiratorno-sintsitial'nogo virusa v Rossii za 2015-2016 gody [Comparative analysis of the epidemiology of influenza and respiratory syntial virus in Russia for 2015-2016]. Epidemiologiya i vaktsinoprofilaktika. 2017;16(1):12-3.
  18. Chertow DS, Memoli MJ. Bacterial coinfection in influenza: A grand rounds review. JAMA. 2013;309(3):275-82. https://doi.org/10.1001/jama.2012.194139
  19. Venkatesan S, Myles PR, Leonardi-Bee J, Muthuri SG, Al Masri M, Andrews N, et al. Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A (H1N1)pdm09 at high risk of hospitalization: An individual participant data metaanalysis. Clin Infect Dis. 2017;64(10):1328-34. https:// doi.org/10.1093/cid/cix127
  20. Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: A meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729-37. https://doi.org/10.1016/S0140-6736(14)62449-1
  21. Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2012;1:CD008965. https://doi. org/10.1002/14651858.CD008965.pub3

Author information:


Larina Nonna Sergeevna
Assistant of the Department of Children's Infections, Astrakhan State Medical University
ORCID ID: 0000-0001-9117-0379
E-mail: nonna11-10@mail.ru

Arakelyan Rudolf Sergeevich
Candidate of Medical Sciences, Associate Professor, Associate Professor of the Department of Infectious Diseases and Epidemiology, Astrakhan State Medical University
ORCID ID: 0000-0001-7549-2925
SPIN: 9245-8543
E-mail: rudolf_astrakhan@rambler.ru

Sivtsova Lyudmila Aleksandrovna
Acting Chief Physician, Center for Hygiene and Epidemiology in the Astrakhan region
ORCID ID: 0000-0002-2169-1141
E-mail: astrfguz@yandex.ru

Kurbangalieva Adelya Rastyamovna
Head of the Epidemiological Department, Center for Hygiene and Epidemiology in the Astrakhan region
ORCID ID: 0000-0002-0078-201X
E-mail: astrfguz-epid@yandex.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:


Arakelyan Rudolf Sergeevich
Candidate of Medical Sciences, Associate Professor, Associate Professor of the Department of Infectious Diseases and Epidemiology, Astrakhan State Medical University

414000, Russian Federation, Astrakhan, Bakinskaya str., 121

Tel.: +7 (927) 2812786

E-mail: rudolf_astrakhan@rambler.ru

Materials on the topic: